
First Malaria Drug approved for Newborns and young infants: Study
Novartis has received approval for Coartem Baby, the world's first malaria treatment specifically for newborns and young infants. Approved by Swiss regulators, the drug is expected to gain swift authorization in eight African countries involved in …